Browse
···
Log in
Graves' Disease - Hyperthyroidism Clinical Study (West Palm Beach)63284078271745120
Graves' Disease - Hyperthyroidism Clinical Study (West Palm Beach)63284078271745121
Graves' Disease - Hyperthyroidism Clinical Study (West Palm Beach)63284078271745122
Graves' Disease - Hyperthyroidism Clinical Study (West Palm Beach)63284078271745123
Graves' Disease - Hyperthyroidism Clinical Study (West Palm Beach)63284078271745124
8
Favourites
Share

Graves' Disease - Hyperthyroidism Clinical Study (West Palm Beach)

address1530 N Flagler Dr, West Palm Beach, FL 33401, USA

Description

Graves’ Disease (Hyperthyroidism) Clinical Study Enrolling Now in West Palm Beach, FL Adults diagnosed with Graves’ Disease (Hyperthyroidism) may qualify for a local clinical trial. The FORWARD trial is evaluating whether an investigational treatment can address the underlying cause of Graves’ disease, and potentially normalize thyroid hormone levels. For more information, call Metabolic Research Institute Inc. show contact info , ext. 8036 or visit: https://www.metabolic-institute.com/graves-disease/ ABOUT METABOLIC RESEARCH INSTITUTE: Clinical studies are an integral part of clinical research and are at the heart of all advances in modern medicine. Our mission at the Metabolic Research Institute is to provide our patients and sponsors with the highest quality of clinical research available in today’s medical professional environment. We are committed to delivering efficient and timely research data, while focusing on strict adherence to protocol guidelines. Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.

Source:  craigslist View Original Post

Location
1530 N Flagler Dr, West Palm Beach, FL 33401, USA
Show Map

craigslist

You may also like

Cookie
Cookie Settings
© 2025 Servanan International Pte. Ltd.